Kidney Disease Clinical Trial
Official title:
The Effects of a Nurse-led Case Management Programme on Home Exercise Training for Haemodialysis Patients
The purpose of this study is to examine the effects of a nurse-led case management programme
on home exercise training for haemodialysis patients. We hypothesised that: a. There is no
significant difference in physical functioning between participants receiving the nurse-led
home exercise training programme and those receiving the comparison care. b. There is no
difference in depression between participants receiving the nurse-led home exercise training
programme and those receiving the comparison care. c. There is no difference in quality of
life and health perception between participants receiving the nurse-led home exercise
training programme and those receiving the comparison care. d. There is no difference in
physical activity levels between participants receiving the nurse-led home exercise training
programme and those receiving the comparison care. e. There is no difference in perceived
benefits and barriers of exercise between participants receiving the nurse-led home exercise
training programme and those receiving the comparison care.
The study was a randomized controlled trial conducted in two haemodialysis units of two
tertiary hospitals in Nanjing, China. Participants were randomly assigned to either study
group or comparison group. Participants in both groups received the in-center exercise
training (20 minutes) before haemodialysis sessions weekly for 6 weeks and were instructed
to perform exercise at home. The in-center training was focused on flexibility and
strengthening exercise. Patients were encouraged to have cardiovascular exercises at home
which will improve their cardiovascular conditions and endurance. The list of cardiovascular
exercise included brisk walking, bicycling, jogging. Participants in the study group were
instructed to start walking or brisk walking at low duration and gradually progress to a
maximum of 30 minutes daily per week. To facilitate exercise progression, the nurse case
managers discussed exercise benefits, explored exercise barriers and developed mutual goals
with patients. The nurse motivated them and checked the exercise behaviors to ensure
adherence to the recommended exercise regime. The nurse case managers interviewed the study
group patients weekly for six weeks and biweekly for another six weeks. Participants in the
comparison group only participated in the in-center exercise training. The comparison group
patients received usual care from the nurse without the interviews and mutual goals
developed.
The duration of interventions was 12 weeks. In-center exercise training sessions were
available for all participants once a week for 6 weeks. Each session lasted about 20
minutes. Participants were instructed to perform flexibility and strength exercise in
centres prior to the haemodialysis session. The researcher performed exercises with the
participants and emphasised the importance of self-monitoring during the sessions. Symptoms
(such as chest pain, dyspnea, dizziness, and leg cramps) and vital signs (blood pressure,
heart rate, and pulse) were checked before exercise and monitored during the entire exercise
session. Participants were instructed to self-monitor exercise intensity. The exercise
programme was pause immediately if the patient was feeling short of breath, chest pain or
pressure, irregular heartbeats, leg cramps, dizziness or lightheadedness, blurring of
vision, or any discomfort.
Intervention group During the study period, participants in the intervention group received
additional face-to-face interviews conducted by the designated case managers every week for
six weeks and biweekly for another six weeks. During interviews, patients were instructed to
start aerobic exercise, such as walking, jogging, cycling, or brisk walking at home at low
duration and gradually progress to a maximum of 30 minutes daily per week. Apart from
aerobic exercise, patients were recommended to perform strength exercises twice a week and
flexibility exercises for every day. The key elements of the interview included: 1)
assessment of patients' knowledge and exercise behaviour; examining patients' attitudes and
feelings about being physical activity; 2) explore patients' barriers to exercise and
perceived benefits; 3) patient education on the benefits of exercise if needed; 4)
development of mutual goals in an exercise plan; 5) explain the purpose of a recording
exercise log and instruction in correct way to keep an exercise diary; 6) discuss the
available supports and resources that could motivate patients to initiate and maintain
exercise, e.g., centre-based exercise programme, support from family members, health care
providers, peer patients, and so forth.
In the follow-up interviews, case managers reviewed the exercise log with participants,
discussed unpleasant experiences related to exercise, exercise progress, and provided
encouragement. According to the progress participants made, the exercise goals and plan were
renewed or revised. Referrals were made as needed.
Comparison group Participants in the comparison group were advised to participate in the
in-centre exercise training programme which was available before haemodialysis sessions once
a week for different shifts of patients. The training session lasted about 20 minutes and
only flexibility and strength training were provided. During the training sessions, patients
were advised to increase their daily activity levels.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02369354 -
Transplant Social Worker Support for Live Kidney Donation in African Americans
|
N/A | |
Not yet recruiting |
NCT02225782 -
Trial to Compare 1.0 Versus 2.0 mg Alteplase (tPA) Dosing in Restoring Hemodialysis Catheter Function
|
Phase 4 | |
Completed |
NCT00499187 -
Fanconi Syndrome Due to ARVs in HIV-Infected Persons
|
Phase 4 | |
Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
Withdrawn |
NCT00585429 -
Evaluation of Kidney Disease in Liver Transplant Recipients
|
N/A | |
Completed |
NCT00183248 -
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
|
Phase 1/Phase 2 | |
Completed |
NCT00001835 -
Oxaliplatin in Cancer Patients With Impaired Kidney Function
|
Phase 1 | |
Completed |
NCT01331941 -
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
|
Phase 1 | |
Terminated |
NCT00436748 -
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
|
Phase 3 | |
Completed |
NCT01467466 -
Prevention of Serious Adverse Events Following Angiography
|
Phase 3 | |
Completed |
NCT01235936 -
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
|
Phase 2 | |
Completed |
NCT01974999 -
A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-01 Study
|
||
Completed |
NCT01947829 -
Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)
|
N/A | |
Recruiting |
NCT01240564 -
The Nephrotic Syndrome Study Network (NEPTUNE)
|
N/A | |
Active, not recruiting |
NCT01228903 -
Uric Acid and the Endothelium is CKD
|
N/A | |
Completed |
NCT00734357 -
Comparative Investigation of Intravenously Administered Omnipaque and Isovue: Effects on Serum Creatinine Concentration in Outpatients
|
N/A | |
Completed |
NCT00781417 -
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
|
N/A | |
Completed |
NCT00094484 -
Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
|
Phase 3 | |
Completed |
NCT00185159 -
Olmesartan Medoxomil in Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT00096915 -
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
|
Phase 3 |